ASPN
Basic information
Region (hg38): 9:92456205-92482506
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASPN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 4 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 3 | 4 | 6 |
Variants in ASPN
This is a list of pathogenic ClinVar variants found in the ASPN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-92457338-G-A | Uncertain significance (-) | |||
9-92460550-A-G | ASPN-related disorder | Likely benign (Aug 20, 2019) | ||
9-92465001-A-T | not specified | Uncertain significance (Jan 31, 2022) | ||
9-92466381-C-T | ASPN-related disorder | Benign (May 08, 2019) | ||
9-92470675-T-A | ASPN-related disorder | Likely benign (Sep 02, 2020) | ||
9-92474742-CTCA-C | Benign (Oct 11, 2021) | |||
9-92474742-C-CTCA | Osteoarthritis susceptibility 3 • Lumbar disk degeneration, susceptibility to • not specified • CENPP-related disorder | Benign (Mar 19, 2020) | ||
9-92474742-C-CTCATCA | Benign (Mar 05, 2021) | |||
9-92474742-C-CTCATCATCA | Uncertain significance (Jun 22, 2023) | |||
9-92474742-C-CTCATCATCATCA | CENPP-related disorder | Benign (Oct 31, 2019) | ||
9-92474742-C-CTCATCATCATCATCA | Benign (Mar 05, 2021) | |||
9-92474766-A-G | ASPN-related disorder | Likely benign (Sep 17, 2019) | ||
9-92474809-A-G | ASPN-related disorder | Likely benign (Apr 28, 2022) | ||
9-92474836-G-T | not specified | Uncertain significance (Aug 30, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASPN | protein_coding | protein_coding | ENST00000375544 | 7 | 26302 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.04e-7 | 0.550 | 125477 | 0 | 263 | 125740 | 0.00105 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.746 | 167 | 196 | 0.850 | 0.00000951 | 2529 |
Missense in Polyphen | 54 | 70.562 | 0.76528 | 953 | ||
Synonymous | 1.63 | 54 | 71.6 | 0.754 | 0.00000356 | 691 |
Loss of Function | 0.993 | 13 | 17.5 | 0.744 | 0.00000108 | 223 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00111 | 0.00111 |
Ashkenazi Jewish | 0.00199 | 0.00199 |
East Asian | 0.000497 | 0.000489 |
Finnish | 0.00130 | 0.00129 |
European (Non-Finnish) | 0.00129 | 0.00125 |
Middle Eastern | 0.000497 | 0.000489 |
South Asian | 0.000834 | 0.000817 |
Other | 0.00148 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: Negatively regulates periodontal ligament (PDL) differentiation and mineralization to ensure that the PDL is not ossified and to maintain homeostasis of the tooth-supporting system. Inhibits BMP2-induced cytodifferentiation of PDL cells by preventing its binding to BMPR1B/BMP type-1B receptor, resulting in inhibition of BMP-dependent activation of SMAD proteins (By similarity). Critical regulator of TGF-beta in articular cartilage and plays an essential role in cartilage homeostasis and osteoarthritis (OA) pathogenesis. Negatively regulates chondrogenesis in the articular cartilage by blocking the TGF- beta/receptor interaction on the cell surface and inhibiting the canonical TGF-beta/Smad signal. Binds calcium and plays a role in osteoblast-driven collagen biomineralization activity. {ECO:0000250, ECO:0000269|PubMed:17827158, ECO:0000269|PubMed:19589127}.;
- Disease
- DISEASE: Osteoarthritis 3 (OS3) [MIM:607850]: A degenerative disease of the joints characterized by degradation of the hyaline articular cartilage and remodeling of the subchondral bone with sclerosis. Clinical symptoms include pain and joint stiffness often leading to significant disability and joint replacement. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Susceptibility to osteoarthritis is conferred by a triplet repeat expansion polymorphism. ASPN allele having 14 aspartic acid repeats in the N-terminal region of the protein (D14), is overrepresented relative to the common allele having 13 aspartic acid repeats (D13). The frequency of the D14 allele increases with disease severity. The D14 allele is also overrepresented in individuals with hip osteoarthritis.; DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common musculo-skeletal disorder caused by degeneration of intervertebral disks of the lumbar spine. It results in low-back pain and unilateral leg pain. {ECO:0000269|PubMed:18304494}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. Susceptibility to intervertebral disk disease, particularly lumbar disk degeneration, is conferred by a triplet repeat expansion polymorphism. ASPN allele having 14 aspartic acid repeats in the N-terminal region of the protein (D14), is associated with the disorder in some populations (PubMed:18304494). {ECO:0000269|PubMed:18304494}.;
- Pathway
- Extracellular matrix organization;ECM proteoglycans
(Consensus)
Recessive Scores
- pRec
- 0.164
Haploinsufficiency Scores
- pHI
- 0.779
- hipred
- N
- hipred_score
- 0.443
- ghis
- 0.584
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.272
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Aspn
- Phenotype
- limbs/digits/tail phenotype;
Gene ontology
- Biological process
- bone mineralization;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of tooth mineralization
- Cellular component
- extracellular matrix;collagen-containing extracellular matrix
- Molecular function
- calcium ion binding;collagen binding;extracellular matrix structural constituent conferring compression resistance